ELOX Projected Dividend Yield
Com New/Eloxx Pharmaceuticals Inc ( OTCBB : ELOX )Eloxx Pharmaceuticals is a biopharmaceutical company engaged in the science of ribosome modulation, utilizing both its TURBO-ZM™ chemistry technology platform and its library of aminoglycosides to develop oral small molecule Ribosome Modulating Agents and Eukaryotic Ribosome Selective Glycosides. Co. has various programs in its pipeline including a clinical program for the treatment of Alport syndrome with ELX-02, preclinical programs in investigational new drug (IND) enabling stages in Recessive Dystrophic and Junctional Epidermolysis Bullosa and Familial Adenomatous Polyposis with ZKN-013, and IND enabling stage program with inhaled delivery of ELX-02 in Class 1 cystic fibrosis. 20 YEAR PERFORMANCE RESULTS |
ELOX Dividend History Detail ELOX Dividend News ELOX Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |